-
Je něco špatně v tomto záznamu ?
Experimental use of flow cytometry to detect bacteria viability after hyperbaric oxygen exposure: Work in progress report
M. Rozloznik, A. Lochmanova, D. Chmelar, M. Hajek, K. Korytkova, M. Cisarikova,
Jazyk angličtina Země Austrálie
Typ dokumentu časopisecké články
PubMed
32557417
DOI
10.28920/dhm50.2.152-156
Knihovny.cz E-zdroje
- MeSH
- Bacteria MeSH
- hyperbarická oxygenace * MeSH
- kyslík MeSH
- mikrobiální viabilita * MeSH
- průtoková cytometrie * MeSH
- výzkumná zpráva MeSH
- Publikační typ
- časopisecké články MeSH
INTRODUCTION: Hyperbaric oxygen treatment (HBOT), based on inhaling pure oxygen under elevated ambient pressure, is used as adjuvant intervention to promote healing in infected wounds. Despite extensive clinical evidence of beneficial effects of HBOT in soft tissue infections the mechanism of action remains to be elucidated. The aim of this study was to evaluate the use of flow cytometry as a novel method to assess the viability of pathogenic bacteria after hyperbaric oxygen (HBO) exposure. METHODS: Bacterial strains associated with soft tissues infections: Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Staphylococcus aureus were exposed to oxygen at 2.8 atmospheres absolute (atm abs) (283.6 kPa) pressure for 45, 90, or 120 min, then stained with propidium iodide and thiazole orange and analysed by flow cytometry. RESULTS: Escherichia coli and Staphylococcus aureus showed no change in viability, nor morphology, the viability of Pseudomonas aeruginosa reduced in a dose-dependent manner and Klebsiella pneumoniae also showed dye uptake after HBO. CONCLUSIONS: These initial results, indicate diverse sensitivity of bacteria to HBO, and suggest that flow cytometry can be used to monitor viability and morphological changes triggered by HBO exposure in bacteria.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20028075
- 003
- CZ-PrNML
- 005
- 20210114152927.0
- 007
- ta
- 008
- 210105s2020 at f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.28920/dhm50.2.152-156 $2 doi
- 035 __
- $a (PubMed)32557417
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a at
- 100 1_
- $a Rozloznik, Miroslav $u Department of Biomedical Sciences, Faculty of Medicine, University of Ostrava, Czech Republic. DAN Europe, Slovensko, Slovakia. DNB consult, s.r.o, Kezmarok, Slovakia. Corresponding author: Dr Miroslav Rozloznik, Department of Biomedical Sciences, Medical Faculty, University of Ostrava, Syllabova 19, Ostrava, Czech Republic, miroslav.rozloznik@osu.cz.
- 245 10
- $a Experimental use of flow cytometry to detect bacteria viability after hyperbaric oxygen exposure: Work in progress report / $c M. Rozloznik, A. Lochmanova, D. Chmelar, M. Hajek, K. Korytkova, M. Cisarikova,
- 520 9_
- $a INTRODUCTION: Hyperbaric oxygen treatment (HBOT), based on inhaling pure oxygen under elevated ambient pressure, is used as adjuvant intervention to promote healing in infected wounds. Despite extensive clinical evidence of beneficial effects of HBOT in soft tissue infections the mechanism of action remains to be elucidated. The aim of this study was to evaluate the use of flow cytometry as a novel method to assess the viability of pathogenic bacteria after hyperbaric oxygen (HBO) exposure. METHODS: Bacterial strains associated with soft tissues infections: Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Staphylococcus aureus were exposed to oxygen at 2.8 atmospheres absolute (atm abs) (283.6 kPa) pressure for 45, 90, or 120 min, then stained with propidium iodide and thiazole orange and analysed by flow cytometry. RESULTS: Escherichia coli and Staphylococcus aureus showed no change in viability, nor morphology, the viability of Pseudomonas aeruginosa reduced in a dose-dependent manner and Klebsiella pneumoniae also showed dye uptake after HBO. CONCLUSIONS: These initial results, indicate diverse sensitivity of bacteria to HBO, and suggest that flow cytometry can be used to monitor viability and morphological changes triggered by HBO exposure in bacteria.
- 650 _2
- $a Bacteria $7 D001419
- 650 12
- $a průtoková cytometrie $7 D005434
- 650 12
- $a hyperbarická oxygenace $7 D006931
- 650 12
- $a mikrobiální viabilita $7 D050296
- 650 _2
- $a kyslík $7 D010100
- 650 _2
- $a výzkumná zpráva $7 D058028
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Lochmanova, Alexandra $u Department of Biomedical Sciences, Faculty of Medicine, University of Ostrava, Czech Republic. Public Health Institute, Ostrava, Czech Republic.
- 700 1_
- $a Chmelar, Dittmar $u Department of Biomedical Sciences, Faculty of Medicine, University of Ostrava, Czech Republic. Czech National Anaerobic Bacteria Reference Laboratory, Faculty of Medicine, University of Ostrava, Czech Republic.
- 700 1_
- $a Hajek, Michal $u Department of Biomedical Sciences, Faculty of Medicine, University of Ostrava, Czech Republic. Centre for Hyperbaric Medicine, City Hospital, Ostrava, Czech Republic.
- 700 1_
- $a Korytkova, Karin $u Department of Biomedical Sciences, Faculty of Medicine, University of Ostrava, Czech Republic.
- 700 1_
- $a Cisarikova, Monika $u Department of Biomedical Sciences, Faculty of Medicine, University of Ostrava, Czech Republic.
- 773 0_
- $w MED00200137 $t Diving and hyperbaric medicine $x 1833-3516 $g Roč. 50, č. 2 (2020), s. 152-156
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32557417 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20210105 $b ABA008
- 991 __
- $a 20210114152925 $b ABA008
- 999 __
- $a ok $b bmc $g 1608410 $s 1119255
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 50 $c 2 $d 152-156 $e 2020Jun30 $i 1833-3516 $m Diving and hyperbaric medicine $n Diving Hyperb Med $x MED00200137
- LZP __
- $a Pubmed-20210105
